Search results
A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants
… The purpose of this trial is to demonstrate the efficacy and safety of everolimus in …
Last Modified:
A Study of the Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors
… This is a randomized, multicenter, open-label, dose-exploration …
Last Modified:
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network- A Longitudinal, Observational Study
… The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing …
Last Modified:
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair (ReChord)
… The objective of this trial is to assess the safety and effectiveness of the study device …
Last Modified:
An Open-Label, Multicenter Phase Ib Study of The Safety and Tolerability of Atezolizumab (Anti-PD-L1 Antibody) Administered in Combination With Bevacizumab and/or Other Treatments in Patients With Solid Tumors
… This purpose of this study is to evaluate the safety and tolerability of study drug …
Last Modified:
Charles J. Lightdale, MD
… Current research is focussed on Barrett's esophagus. Targeted biopsies using …
Last Modified:
A 24-month, multi-center, single arm, prospective study to evaluate renal function, efficacy, safety and tolerability of everolimus in combination with reduced exposure cyclosporine or tacrolimus in paediatric liver transplant : CRAD001H2305
… This study is designed to assess the evolution of renal function and to …
Last Modified:
Liver Disease – An Introduction
… the most common types of liver disease, as well as who is most at risk for developing liver disease. Learn more …
Last Modified:
Liver Disease – Hepatitis B
… at Columbia, discusses Hepatitis B in detail. Hepatitis B is the most common form of viral hepatitis in the world, and …
Last Modified:
Dr. Brown – Hepatitis C
… University, discusses Hepatitis C. Dr. Brown discusses who is at greatest risk for hepatitis C, and the latest on the …
Last Modified:
CTOTC Alloantibodies in Cardiac Transplantation: interventions, outcomes and mechanisms
… The purpose of this study is to determine the clinical outcomes of sensitized pediatric …
Last Modified:
A Phase 3b study to evaluate the long-term outcomes following treatment with Abbvie DAAs and with or without Ribavirin (RBV) in adults with genotype 1 Chronic Hepatitis C Virus (HCV) Infection
… The purpose of this study is to evaluate Long-term Outcomes following treatment with …
Last Modified:
Genetic Testing and Cancer Screening
… population, the risk of developing colorectal cancer is anywhere from 6-9%. However, for patients with certain …
Last Modified:
How do living donor and deceased donor liver transplants compare?
… Dr. Tomoaki Kato to learn why the timing of a transplant is also an important factor. Learn more about types of liver …
Last Modified:
Miracles Happen The Story of Regina Williams
… result from hard work; the loving generosity of a son is not unknown or unique. How everything came together in … in which one-half to two-thirds of the donor's liver is transplanted. The donor's remaining liver quickly … great, livers functioning perfectly. Proof of success is that mean jitterbug Paul and I did six months later, at …
Last Modified: